Literature DB >> 23946711

Delayed diagnosis, range of severity, and multiple sleep comorbidities: a clinical and polysomnographic analysis of 100 patients of the innsbruck narcolepsy cohort.

Birgit Frauscher1, Laura Ehrmann, Thomas Mitterling, David Gabelia, Viola Gschliesser, Elisabeth Brandauer, Werner Poewe, Birgit Högl.   

Abstract

STUDY
OBJECTIVES: Narcolepsy is reported to affect 26-56/100,000 in the general population. We aimed to describe clinical and polysomnographic features of a large narcolepsy cohort in order to comprehensively characterize the narcoleptic spectrum.
METHODS: We performed a chart- and polysomnographybased review of all narcolepsy patients of the Innsbruck narcolepsy cohort.
RESULTS: A total of 100 consecutive narcolepsy patients (87 with cataplexy [NC], 13 without cataplexy [N]) were included in the analysis. All subjects had either excessive daytime sleepiness or cataplexy as their initial presenting clinical feature. Age at symptom onset was 20 (6-69) years. Diagnostic delay was 6.5 (0-39) years. The complete narcolepsy tetrad was present in 36/100 patients; 28/100 patients had three cardinal symptoms; 29/100 had two; and 7/100 had only excessive daytime sleepiness. Severity varied broadly with respect to excessive daytime sleepiness (median Epworth Sleepiness Scale score: 18, range 10-24), cataplexy (8-point Likert scale: median 4.5, range 1-8), hypnagogic hallucinations (median 4.5, range 1-7), and sleep paralysis (median 3, range 1-7). Sleep comorbidity was highly prevalent and ranged from sleeprelated movement disorders (n = 55/100), parasomnias (n = 34/100), and sleeprelated breathing disorders (n = 24/100), to insomnia (n = 28/100). REM sleep without atonia or a periodic limb movement in sleep index > 5/h were present in most patients (90/100 and 75/100). A high percentage of narcoleptic patients in the present study had high frequency leg movements (35%) and excessive fragmentary myoclonus (22%). Of the narcolepsy patients with clinical features of REM sleep behavior disorder (RBD), 76.5% had EMG evidence for RBD on the multiple sleep latency test (MSLT), based on a standard cutoff of a minimum of 18% of 3-sec miniepochs.
CONCLUSION: This study is one of the largest monocentric polysomnographic studies to date of patients with narcolepsy and confirms the frequent comorbidity of narcolepsy with many other sleep disorders. Our study is the first to evaluate the percentage of patients with high frequency leg movements and excessive fragmentary myoclonus in narcolepsy and is the first to demonstrate EMG evidence of RBD in the MSLT. These findings add to the growing body of literature suggesting that motor instability is a key feature of narcolepsy.

Entities:  

Keywords:  Polysomnography; cohort; diagnosis; gender; hypersomnia; hypocretin; sleep paralysis

Mesh:

Year:  2013        PMID: 23946711      PMCID: PMC3716672          DOI: 10.5664/jcsm.2926

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  39 in total

1.  Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.

Authors:  Masaki Nakamura; Takashi Kanbayashi; Tatsuki Sugiura; Yuichi Inoue
Journal:  J Sleep Res       Date:  2011-03       Impact factor: 3.981

2.  Narcolepsy in New Zealand: pathway to diagnosis and effect on quality of life.

Authors:  Angela J Campbell; T Leigh Signal; Karyn M O'Keeffe; Jessie P Bakker
Journal:  N Z Med J       Date:  2011-06-10

3.  Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine.

Authors:  Friederike Sixel-Döring; Marcus Schweitzer; Brit Mollenhauer; Claudia Trenkwalder
Journal:  J Clin Sleep Med       Date:  2011-02-15       Impact factor: 4.062

4.  Motor disturbances during non-REM and REM sleep in narcolepsy-cataplexy: a video-polysomnographic analysis.

Authors:  Birgit Frauscher; Viola Gschliesser; Elisabeth Brandauer; Suzana V Schönwald; Tina Falkenstetter; Laura Ehrmann; Ismail Tokmak; Werner Poewe; Birgit Högl
Journal:  J Sleep Res       Date:  2011-01-25       Impact factor: 3.981

5.  Fragmentary myoclonus in sleep revisited: a polysomnographic study in 62 patients.

Authors:  Birgit Frauscher; Alexander Kunz; Elisabeth Brandauer; Hanno Ulmer; Werner Poewe; Birgit Högl
Journal:  Sleep Med       Date:  2011-04       Impact factor: 3.492

6.  Restless legs syndrome is frequent in narcolepsy with cataplexy patients.

Authors:  Giuseppe Plazzi; Raffaele Ferri; Elena Antelmi; Sophie Bayard; Christian Franceschini; Filomena I I Cosentino; Beatriz Abril; Karen Spruyt; Federica Provini; Pasquale Montagna; Yves Dauvilliers
Journal:  Sleep       Date:  2010-05       Impact factor: 5.849

7.  Clinical and polysomnographic characteristics of high frequency leg movements.

Authors:  Changkook Yang; John W Winkelman
Journal:  J Clin Sleep Med       Date:  2010-10-15       Impact factor: 4.062

8.  Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.

Authors:  Mona S Heier; Tine S Jansson; Kaare M Gautvik
Journal:  J Clin Sleep Med       Date:  2011-12-15       Impact factor: 4.062

9.  Health-related quality of life in patients with narcolepsy.

Authors:  Richard Dodel; Helga Peter; Annika Spottke; Carmen Noelker; Astrid Althaus; Uwe Siebert; Tobias Walbert; Karl Kesper; Heinrich F Becker; Geert Mayer
Journal:  Sleep Med       Date:  2007-05-18       Impact factor: 3.492

10.  Complex movement disorders at disease onset in childhood narcolepsy with cataplexy.

Authors:  Giuseppe Plazzi; Fabio Pizza; Vincenzo Palaia; Christian Franceschini; Francesca Poli; Keivan K Moghadam; Pietro Cortelli; Lino Nobili; Oliviero Bruni; Yves Dauvilliers; Ling Lin; Mark J Edwards; Emmanuel Mignot; Kailash P Bhatia
Journal:  Brain       Date:  2011-09-19       Impact factor: 13.501

View more
  30 in total

1.  A 62-year-old Man with Facial and Finger Twitching.

Authors:  Stuart J McCarter; Erik K St Louis
Journal:  J Clin Sleep Med       Date:  2016-02       Impact factor: 4.062

2.  The Treatment of Narcolepsy With Amphetamine-Based Stimulant Medications: A Call for Better Understanding.

Authors:  Moshe Turner
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

3.  Time for a standardized clinical assessment for narcolepsy with obstructive sleep apnea.

Authors:  Vincent Mysliwiec; Matthew S Brock
Journal:  Sleep Breath       Date:  2017-06-16       Impact factor: 2.816

4.  Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders.

Authors:  Francesca Canellas; Ling Lin; Maria Rosa Julià; Antonio Clemente; Cristofol Vives-Bauza; Hanna M Ollila; Seung Chul Hong; Susana M Arboleya; Mali A Einen; Juliette Faraco; Marcelo Fernandez-Vina; Emmanuel Mignot
Journal:  J Clin Sleep Med       Date:  2014-09-15       Impact factor: 4.062

5.  Giving a voice to cataplectic experience: recollections from patients with narcolepsy type 1.

Authors:  Christian Franceschini; Chiara Fante; Maria Claudia Folli; Maria Filosa; Fabio Pizza; Elena Antelmi; Francesca Ingravallo; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

6.  Update on therapy for narcolepsy.

Authors:  Michael J Thorpy
Journal:  Curr Treat Options Neurol       Date:  2015-05       Impact factor: 3.598

Review 7.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

8.  Hypocretin-1 Levels Associate with Fragmented Sleep in Patients with Narcolepsy Type 1.

Authors:  Anniina Alakuijala; Tomi Sarkanen; Markku Partinen
Journal:  Sleep       Date:  2016-05-01       Impact factor: 5.849

9.  Medical specialty visits and diagnoses received by Saudi patients prior to a diagnosis of narcolepsy.

Authors:  Aljohara S Almeneessier; Sara Al-Jebrin; Reem Labani; Hussain Alkaff; Omar Al-Rahbeeni; Musab Alageel; Awad Olaish; Ahmed S BaHammam
Journal:  Sleep Breath       Date:  2019-02-28       Impact factor: 2.816

10.  Dream enactment behavior: review for the clinician.

Authors:  Marc Baltzan; Chun Yao; Dorrie Rizzo; Ron Postuma
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.